Remote patient monitoring provider Sibel Health has launched a new monitoring tool, Discovery, which uses Sibel's FDA-approved wearable sensors to monitor participants' vital signs, including heart rate, blood pressure, respiratory rate, temperature, and oxygen saturation.

Sibel additionally has partnered with healthcare evidence provider Medidata to integrate Sibel's Discovery platform into Medidata's cloud-based platform. Through the partnership, Medidata's platform will allow academic researchers and pharmaceutical, biotechnology, medical device, and diagnostics companies to access Sibel participants' data.